The rationale for curative radiotherapy in mycosis fungoides.

[1]  A. Ahmed,et al.  Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders. , 1975, Annals of internal medicine.

[2]  P. Wiernik,et al.  MANAGEMENT OF MYCOSIS FUNGOIDES—CURRENT STATUS AND FUTURE PROSPECTS , 1975, Medicine.

[3]  Z. Fuks,et al.  NEW CONCEPTS IN THE MANAGEMENT OF MYCOSIS FUNGOIDES , 1974, The British journal of dermatology.

[4]  Z. Fuks,et al.  Prognostic signs and the management of the mycosis fungoides , 1973, Cancer.

[5]  E. V. Van Scott,et al.  Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic tolerance , 1973, Cancer.

[6]  Vania Phuoc,et al.  Mycosis Fungoides , 1973, The British journal of clinical practice.

[7]  M. Lutzner,et al.  MYCOSIS FUNGOIDES: Survival, Prognostic Features, Response to Therapy, and Autopsy Findings , 1972, Medicine.

[8]  Z. Fuks,et al.  Total-skin electron treatment of mycosis fungoides. , 1971, Radiology.

[9]  C. J. Karzmark,et al.  Patient dosimetry in the electron treatment of large superficial lesions. , 1970, Radiology.

[10]  M. Bagshaw,et al.  Observations on the Electron Beam Therapy of Mycosis Fungoides1 , 1968 .

[11]  H. N. Magoun.  Thomas, Springfield, Illinois , 1965 .

[12]  A. Eisen,et al.  Mycosis fungoides: Natural history and aspects of its relationship to other malignant lymphomas , 1963 .

[13]  J. G. Trump,et al.  High energy electrons for the treatment of extensive superficial malignant lesions. , 1953, The American journal of roentgenology, radium therapy, and nuclear medicine.

[14]  J BERKSON,et al.  Calculation of survival rates for cancer. , 1950, Proceedings of the staff meetings. Mayo Clinic.

[15]  S. Bluefarb.  Cutaneous manifestations of the malignant lymphomas , 1959 .